-
Innovation Ranking
NewInnovation Ranking – bioMerieux SA
bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures, and markets in vitro diagnostic solutions for hospital and private laboratories. The company offers diagnostic solutions such as systems, reagents and software for the diagnosis of infectious diseases, cardiovascular diseases and cancers, besides identifying microorganisms in pharmaceuticals, cosmetics, and agri-food products. It offers immunoassays, microbiology products, molecular biology tests, and other solutions for clinical applications and industrial microbiological control solutions for the food, biopharmaceutical, and cosmetic industries; veterinary diagnostic...
-
Company Insights
Innovation and Patenting activity of bioMerieux SA Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of bioMerieux SA Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Sector Analysis
NewImmunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Immunochemistry Analyzers Market Report Overview The immunochemistry analyzers market size was valued at $1.41 billion in 2023 and is expected to grow at a CAGR of more than 4% during 2023-2033. Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins, and therapeutic drugs. They are typically offered in modular increments, which can operate independently or simultaneously as a unit. Immunochemistry Analyzers Market Outlook, 2023-2033 ($ Billion) Buy the Full Report for More Insights into...
-
Sector Analysis
NewPolymerase Chain Reaction (PCR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
The PCR Market Report Overview The PCR market size was $700.3 million in 2023. Factors such as recent technological advances will drive the market growth at a CAGR of more than 5% from 2023 to 2033. Polymerase Chain Reaction (PCR) systems are used for nucleic acid amplification. They are commonly employed in investigations related to the diagnosis or prognosis of cancer or infectious diseases. The Polymerase chain reaction (PCR) is a method used to amplify short DNA or RNA sequences...
-
Product Insights
Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Sector Analysis
Helicobacter Pylori Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Helicobacter Pylori Tests Market Report Overview The Helicobacter Pylori Tests market size was valued at $338.5 million in 2023. The Helicobacter Pylori Tests market will grow at a CAGR of more than 2% from 2023 to 2033. H. pylori has been recognized as a Class I carcinogen by the International Agency for Research on Cancer and as one of the strongest known risk factors for gastric malignancies such as peptic ulcer disease, gastric MALT lymphoma and gastric cancer as 89%...
-
Sector Analysis
Bordetella pertussis (Whooping Cough) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Bordetella pertussis (Whooping Cough) Tests Market Report Overview The Bordetella pertussis (Whooping Cough) test market size was $31.7 million in 2023 and will grow at a declining CAGR of less than 1% from 2023 to 2033. Bordetella pertussis (Whooping Cough) tests are carried out to detect infections caused by the bacterium Bordetella pertussis, using a combination of molecular techniques, immunoassay, and other techniques. Bordetella pertussis (Whooping Cough) Tests Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights...
-
Sector Analysis
COVID-19 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
COVID-19 tests Market Report Overview The COVID-19 tests market size was valued at $23.97 billion in 2023. The market will decline at a CAGR of more than 22%. COVID-19 tests are used to screen for and identify infections caused by the SARS-CoV-2- coronavirus, an emerging pathogen that was first discovered in China in the early 21st century. The COVID-19 test can be performed using point-of-care rapid testing, laboratory-based ELISA testing, or PCR. COVID-19 Tests Market Outlook 2023-2033 ($ Billion) Buy...
-
Sector Analysis
BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
BRAF Tests Market Report Overview The BRAF Tests market size was valued at $32.8 million in 2023. The market is expected to grow at a CAGR of more than 6% during 2023-2033. BRAF Sanger sequencing Tests are used when complete sequencing of the BRAF gene is required for accurate detection and mapping of mutations. Sanger sequencing is a DNA sequencing technique that uses modified, chain-terminating dideoxynucleotides (ddNTPs). BRAF Tests Market Outlook 2023-2023 ($ Million) Buy The Full Report for More...
-
Sector Analysis
Lyme Disease Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Lyme Disease Tests Market Overview The Lyme disease tests market size was valued at $11.3 million in 2023. The Lyme disease tests market will grow at a CAGR of more than 6% from 2023 to 2033. The tests help to diagnose infections caused by the tick-borne bacterium Borrelia, which can result in neurological and joint disease. Lyme Disease Tests Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights on the Lyme Disease Tests Market Forecast, Download a...